CVS Health Corporation Common Stock (CVS)
Stock · NYSE · Consumer Staples
$92.39as of 10/16/2026
Price chart
Active signals
CVS Signal Track Record
How signals performed across all stocks →What CVS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 32 | +1.8% | 56% | September 18, 2026 |
| Bollinger Band BreakoutActive now | 25 | +1.1% | 52% | July 21, 2026 |
| Bollinger Band Breakdown | 21 | +2.8% | 57% | September 17, 2026 |
| 200-Day Moving Average TouchActive now | 14 | +2.1% | 50% | October 8, 2026 |
| Any 20-session window (baseline) | +0.3% | 52% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CVS
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care managemen…
- Sector
- Consumer Staples
- Industry
- Retail-Drug Stores and Proprietary Stores
- Employees
- 219,000
- Website
- cvshealth.com/
Fundamentals
- 1-day range
- $91$92.64
- Market cap
- $122.77B
- P/E (trailing)
- 23.91
- P/E (forward)
- 10.85
- EPS (trailing)
- $3.77
- Dividend yield
- 3.49%
- Beta
- 0.59
- Avg. volume
- 8.08M
- Ex-dividend date
- October 22, 2026
- Dividend pay date
- November 2, 2026
How CVS Health Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 10, 2026 · via SEC EDGAR / Finnhub
Forecasts
25 analyst ratings
CVS Health Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- CVSCVS Health Corporation Common Stock$92.36▼ 0.24%Market cap $122.77BP/E 23.91$69.51$110.68
- GRDNGuardian Pharmacy Services Inc. Class A Common Stock$39.47▼ 0.53%Market cap $2.50BP/E 38.13$23.37$48.33
- PETSPetMed Express Inc. Common Stock$1.18▼ 3.28%Market cap $42.10MP/E —$1.26$4.1
- YI111 Inc. American Depositary Shares$3.13▲ 1.29%Market cap $33.34MP/E —$2.48$11.17
- RDGTRidgetech Inc. Ordinary Shares$0.84▲ 1.20%Market cap $2.85MP/E 0.24$0.67$760.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CVS CVS Health Corporation Common Stock | $122.77B | 23.91 | $92.36 | ▼ 0.24% | $69.51$110.68 |
| GRDN Guardian Pharmacy Services Inc. Class A Common Stock | $2.50B | 38.13 | $39.47 | ▼ 0.53% | $23.37$48.33 |
| PETS PetMed Express Inc. Common Stock | $42.10M | — | $1.18 | ▼ 3.28% | $1.26$4.1 |
| YI 111 Inc. American Depositary Shares | $33.34M | — | $3.13 | ▲ 1.29% | $2.48$11.17 |
| RDGT Ridgetech Inc. Ordinary Shares | $2.85M | 0.24 | $0.84 | ▲ 1.20% | $0.67$760.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Marginsbenzinga · 10/13/2026
- How New Pharmacy Formats And Aetna Star Ratings At CVS Health (CVS) Have Changed Its Investment StoryYahoo · 10/10/2026
- Jim Cramer Breaks Down the Complicated Story Behind CVS Health’s (CVS) DeclineYahoo · 10/10/2026
- Big Tech is betting $700 billion on AI. Healthcare will decide whether the bet pays offYahoo · 10/10/2026
- CVS Says Its Star Ratings Are Strong. TD Cowen Sees a $0.41 Earnings HitYahoo · 10/10/2026
- Humana Leads Managed Care Peers in 2027 Medicare Advantage Star Ratings, Deutsche Bank SaysYahoo · 10/9/2026
- CVS Stock Dips After Drop in Medicare Advantage Plan RatingsYahoo · 10/9/2026
- CVS Health (CVS) vs Cigna (CI): Which is a Better Stock to Buy?Yahoo · 10/9/2026
- At 71, She Chose Humana for the Part B Giveback in Her Social Security Check. For 2027, Humana Will Cut or Eliminate It for 62% of Those MembersYahoo · 10/9/2026
Insider Activity
Insider Actions →- Brian Newman · May 31, 2026 · Tax Withholding2.5K @ $90.98
- Amy Compton-Phillips · May 31, 2026 · Tax Withholding7.6K @ $90.98
- Fernando Aguirre · May 21, 2026 · Disposition1.6K @ $93.5
- Larry Robbins · May 21, 2026 · Sale378.0K @ $93.31
- Larry Robbins · May 21, 2026 · Sale370.5K @ $93.45
- Larry Robbins · May 20, 2026 · Sale797.6K @ $93.48
- Larry Robbins · May 20, 2026 · Sale66.9K @ $95.67
- Fernando Aguirre · May 20, 2026 · Disposition30.4K @ $93.78
- Larry Robbins · May 20, 2026 · Sale800 @ $96.28
- Larry Robbins · May 20, 2026 · Sale152.7K @ $94.81
- Larry Robbins · May 19, 2026 · Sale151 @ $95.18
- Larry Robbins · May 19, 2026 · Sale1.98M @ $94.45
- Finucane Anne A. · May 14, 2026 · Grant1.5K @ $97.15
- Guy P. Sansone · May 14, 2026 · Grant1.4K @ $97.15
- Douglas H. Shulman · May 14, 2026 · Grant1.4K @ $97.15
Institutional Ownership
March 31, 2026
- Total shares held
- 1.06B
- Total value held
- $73.07B
- Institutional holders
- 1850
- Unknown125.92M
- Unknown82.65M
- Unknown77.25M
- Unknown59.32M
- Unknown51.78M
- Unknown31.20M
- Unknown29.46M
- Unknown25.14M
- Unknown23.78M
- Unknown22.57M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.